Beranda › Limfoma Sel B Besar Difus › Wisconsin › Milwaukee
Uji klinis Limfoma Sel B Besar Difus di Milwaukee, WI
16 studi untuk Limfoma Sel B Besar Difus mencari peserta di lokasi sekitar Milwaukee (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Menerima pesertaStudi observasional
- Children's Hospital of Wisconsin, Milwaukee
Testing the Effectiveness of a Combination Targeted Therapy (ViPOR) for Patients With Relapsed and/or Refractory Aggressive B-cell Lymphoma
Menerima pesertaFase 2
- Medical College of Wisconsin, Milwaukee
- Drexel Town Square Health Center, Oak Creek · 11 mi jauhnya
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 11 mi jauhnya
- dan 3 lainnya
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Menerima pesertaFase 2
- Medical College of Wisconsin ( Site 0103), Milwaukee
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Menerima pesertaFase 1
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Menerima pesertaFase 1
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of ARC-02 in B-cell NHL
Menerima pesertaFase 1
- Froedtert & Medical College of Wisconsin, Milwaukee
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
Menerima pesertaFase 1/2
- Medical College of Wisconsin, Milwaukee
Mosunetuzumab and Polatuzumab Vedotin With Split-Dose CHP Chemotherapy for Elderly Patients With Diffuse Large B-Cell Lymphoma
Menerima pesertaFase 2
- Froedtert Hospital & the Medical College of Wisconsin, Milwaukee
LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies
Menerima pesertaFase 1
- Froedtert & the Medical College of Wisconsin, Milwaukee
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
Menerima pesertaStudi observasional
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
DALY II USA/ MB-CART2019.1 for DLBCL
Menerima pesertaFase 2
- Froedtert Hospital and the Medical College of Wisconsin, Milwaukee
A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
Menerima pesertaFase 1
- Medical College of Wisconsin, Milwaukee
CAR-20/19-T Cells in Patients With Relapsed Refractory B Cell Malignancies
Menerima pesertaFase 1/2
- Medical College of Wisconsin and Froedtert Hospital, Milwaukee
Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
Menerima pesertaFase 2
- Medical College of Wisconsin, Milwaukee
- Froedtert and MCW Moorland Reserve Health Center, New Berlin · 11 mi jauhnya
Long-term Follow-up Study of Patients Receiving CAR-T Cells
Menerima pesertaStudi observasional
- Froedtert Hospital & Medical College of Wisconsin, Milwaukee
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Menerima pesertaFase 2
- Aurora Cancer Care-Milwaukee, Milwaukee
- Aurora Saint Luke's Medical Center, Milwaukee
- Aurora Sinai Medical Center, Milwaukee
- dan 4 lainnya
Uji klinis Limfoma Sel B Besar Difus di kota lain
- New York City, NY21 studi
- Baldwin Park, CA19 studi
- Chicago, IL18 studi
- Houston, TX17 studi
- Los Angeles, CA17 studi
- Boston, MA16 studi
- Nashville, TN15 studi
- Portland, OR15 studi
- Philadelphia, PA15 studi
- Durham, NC14 studi
- Dallas, TX13 studi
- Seattle, WA12 studi
Studi lain di Milwaukee
- Kanker Payudara23 studi
- Kanker Paru Non-Sel Kecil22 studi
- Kanker (semua jenis)22 studi
- Kanker Paru21 studi
- Mieloma Multipel21 studi
- Kanker Prostat20 studi
- Limfoma Folikuler19 studi
- Kanker Pankreas18 studi
- Limfoma Non-Hodgkin18 studi
- Kanker Ovarium17 studi
- Leukemia Mieloid Akut17 studi
- Limfoma Burkitt16 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.